[How to approach management of surgical vitreoretinal disease during the SARS-CoV-2 Covid-19 pandemic?]

J Fr Ophtalmol. 2020 Jun;43(6):533-534. doi: 10.1016/j.jfo.2020.04.011. Epub 2020 Apr 30.

[Article in French]

Authors

C Arndt¹, M-N Delyfer¹, L Kodjikian², N Leveziel¹, C Zech¹

Affiliations

¹ Société Française d'Ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France.
² Société Française d'Ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France. Electronic address: kodjikian.laurent@wanadoo.fr.

No abstract available

Publication types

Practice Guideline

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections / epidemiology*
Emergencies
Eye Diseases / surgery
Humans
Ophthalmologic Surgical Procedures / classification
Pandemics*
Pneumonia, Viral / epidemiology*
Retinal Diseases / surgery*
SARS-CoV-2
Vitreous Body / surgery*